Welcome to Multibagg AI
Log in to access personalized features
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Investor Presentation
Q4 FY26
Investor Presentation
Q3 FY26
Investor Presentation
Q2 FY26
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q1 FY26
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q4 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q3 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q2 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q1 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Discovery themes featuring this stockDiscovery themes featuring this stock| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
233.15 | 3,060 Cr | 168.42 | 4.38 | 0.06 | 2.60 | 4.13 | 1.62 | ||
1370.10 | 2,294 Cr | 15.74 | 1.80 | 0.00 | 11.43 | 15.51 | 10.17 | ||
705.35 | 2,052 Cr | 14.72 | 1.68 | 0.00 | 11.42 | 14.78 | 6.97 | ||
153.70 | 1,774 Cr | 14.80 | 1.76 | 0.49 | 11.86 | 15.46 | 8.96 | ||
770.50 | 1,718 Cr | -21.23 | 4.40 | 0.00 | -20.72 | -5.54 | -8.59 | ||
47.29 | 1,203 Cr | 41.86 | 0.78 | 0.00 | 1.86 | 6.75 | 0.95 | ||
920.00 | 1,135 Cr | 17.75 | 2.68 | 0.32 | 15.10 | 17.43 | 7.77 | ||
| Median: 7 Co. | — | 705.35 | 1,774 Cr | 15.74 | 1.80 | 0.00 | 11.42 | 14.78 | 6.97 |
Insecticides (India) Limited is a leading agrochemical company focused on the manufacturing and distribution of a wide range of crop protection products including insecticides, herbicides, and fungicides.
In the recent years, IIL has significantly advanced its R&D capabilities through collaborations with global players like Nissan and Corteva, launching innovative and high-margin products.
The company has shown marked improvement in its financial performance with a focus on premiumization and expansion which propelled an increase in B2C premium product share to 61% by FY25.
Strategic capacity expansions at its manufacturing facilities and the acquisition of Kaeros Research Ltd. enhance IIL's supply chain and operational efficiency, ensuring better market competitiveness.
IIL has a robust strategic plan to maintain double-digit growth through targeted product launches and strategic tie-ups, aiming for long-term sustainability and market leadership.
Fertilizers & Agrochemicals
Pesticides & Agrochemicals
2,052 Cr
Low Risk
14.7
20.9
0.7
1.7
1,096.30
525.90
Sales CAGR
Profit CAGR
ROE
ROCE
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Insecticides India Ltd (INSECTICID) is currently trading at 724.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Insecticides (India) Limited is a leading agrochemical company focused on the manufacturing and distribution of a wide range of crop protection products including insecticides, herbicides, and fungicides. In the recent years, IIL has significantly advanced its R&D capabilities through collaborations with global players like Nissan and Corteva, launching innovative and high-margin products. The company has shown marked improvement in its financial performance with a focus on premiumization and expansion which propelled an increase in B2C premium product share to 61% by FY25. Strategic capacity expansions at its manufacturing facilities and the acquisition of Kaeros Research Ltd. enhance IIL's supply chain and operational efficiency, ensuring better market competitiveness. IIL has a robust strategic plan to maintain double-digit growth through targeted product launches and strategic tie-ups, aiming for long-term sustainability and market leadership.
Over the past 52 weeks, Insecticides India Ltd has traded between a low of ₹525.90 and a high of ₹1,096.30. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Insecticides India Ltd has a market capitalization of approximately 2,052.42. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Insecticides India Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 14.72 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 2,052.42 Cr, Insecticides India Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Insecticides India Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Insecticides India Ltd is 14.72. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
The stock fell over 9% because the company's net profit declined by nearly 40% year-on-year, and its operating margins narrowed despite an increase in revenue.
Bearish
3
Neutral
8
Bullish
3
Bearish
11
Neutral
9
Bullish
26
Bearish
8
Neutral
1
Bullish
23
Earnings Call Transcript
Transcript of Insecticides India’s Q4 & FY26 earnings call: Q4 revenue up ~19% (premium +24%), FY revenue >7% with broadly profit‑neutral results; highlighted global partnerships, new product launches, elevated working capital and FY27 maintenance capex of INR25–30 Cr.
Earnings Transcript
Transcript of Insecticides India’s Q4 & FY2026 earnings call: Q4 revenue grew ~19% (premium products +24%), FY sales >7% with broadly profit‑neutral results; strategy focuses on premiumization, R&D and global partnerships; working capital elevated and maintenance capex of INR25–30 crore guided for FY27.
